ArticleAnnals of the American Thoracic Society2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in Annals of the American Thoracic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 19 citations in OpenAlex.
- Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management.Pulmonary circulation · 2026Review
- Poverty and Social Deprivation in Patients With Pulmonary Arterial Hypertension-A PHAR Analysis.Pulmonary circulation · 2026Article
- Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care Workstream.Pulmonary circulation · 2026Article
- Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies.Advances in therapy · 2026Observational
- Global pulmonary arterial hypertension trends and projections to 2046: a multi-method analysis of epidemiologic and demographic drivers using GBD 2021.Journal of thoracic disease · 2025Article
- Complex Interactions of Social Determinants of Health on Survival Outcomes in Hispanic Patients With Pulmonary Arterial Hypertension in a US-Mexican Border City.Cardiology research · 2025Article
- Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990-2021.BMJ open · 2025Article
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation · 2025Review
- A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025Review
- Exploring the patient perspective in pulmonary hypertension.The European respiratory journal · 2024Article
- The impact of group II pulmonary hypertension on congestive heart failure patients admitted with ST elevation myocardial infarction, a nationwide study.Journal of thoracic disease · 2024Article
- Insights Into Differences in Pulmonary Hemodynamics in Hispanic Patients With Pulmonary Arterial Hypertension.Cardiology research · 2024Article
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation · 2024Review
- Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.Annals of the American Thoracic Society · 2023Article
- Differential drug response in pulmonary arterial hypertension: The potential for precision medicine.Pulmonary circulation · 2023Review
- Pulmonary Hypertension: A Contemporary Review.American journal of respiratory and critical care medicine · 2023Review
- Health Care Disparities in Pulmonary Arterial Hypertension.Clinics in chest medicine · 2023Review
- Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models.Pulmonary circulation · 2023Article
- Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.Pulmonary circulation · 2023Article
- The social and economic disadvantage in pulmonary hypertension: A work (still) in progress.Pulmonary circulation · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 11 institutions in 1 country.
Roberto J BernardoDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.ORCID 0000-0002-6882-997X
Di LuQuantitative Sciences Unit and.
Ramon L RamirezDivision of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California.
Haley HedlinQuantitative Sciences Unit and.
Steven M KawutDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Todd BullDivision of Pulmonary and Critical Care Medicine, University of Colorado, Denver, Colorado.
Teresa De MarcoDivision of Cardiology, University of California San Francisco, San Francisco, California.
H James FordDivision of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Daniel GrinnanDivision of Pulmonary and Critical Care Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia.
James R KlingerDivision of Pulmonary and Critical Care Medicine, Brown University, Providence, Rhode Island.
John W McConnellKentuckiana Pulmonary Associates, Louisville, Kentucky.
Erika Berman-RosenzweigDepartment of Pediatrics, Columbia University, New York, New York; and.
Oksana A ShlobinInova Fairfax Hospital, Falls Church, Virginia.
Roham T ZamanianDivision of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California.
Vinicio A de Jesus PerezDivision of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California.
Stanford University · USBrown University · USColumbia University · USInova Fairfax Hospital · USKentuckiana Pulmonary Associates · USUniversity of California, San Francisco · USUniversity of Colorado Denver · USUniversity of North Carolina at Chapel Hill · USUniversity of Oklahoma Health Sciences Center · USUniversity of Pennsylvania · USVirginia Commonwealth University Medical Center · US
Funding
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertensionR01HL134776 · NHLBI · STANFORD UNIVERSITY · PI DE JESUS PEREZ, VINICIO A · 2017 to 2025
$5.0MEndothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertensionR01HL139664 · NHLBI · STANFORD UNIVERSITY · PI DE JESUS PEREZ, VINICIO A · 2018 to 2025
$4.7MNHLBI NIH HHS R01 HL134776NHLBI NIH HHS R01 HL139664
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PulmonaryPulmonary Arterial HypertensionAdultFamilial Primary Pulmonary HypertensionHumansProspective StudiesRegistriesSocial Determinants of HealthUnited StatesethnicityHispanicsPHARpulmonary arterial hypertensionsocial determinants of health
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.